Michael Hochman
- Department of Hematology and Medical Oncology
Assistant Professor
- (404) 778-5536
- michael.jamie.hochman@emory.edu
Academic Appointment
- Assistant Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine
Education
Degrees
- MD from Duke University School of Medicine
Research
Publications
-
SOHO State of the Art Updates and Next Questions | Choosing and Properly Using a JAK Inhibitor in Myelofibrosis.
Clin Lymphoma Myeloma Leuk Volume: 25 Page(s): 226 - 239
04/01/2025 Authors: Hochman MJ; Vale CA; Hunter AM -
Dissecting Out a Rare Mutation, STAT: Features of STAT3-Mutant Myeloid Neoplasms.
Clin Cancer Res Volume: 30 Page(s): 4554 - 4556
10/15/2024 Authors: Hochman MJ; Frank DA -
SOHO State of the Art Updates and Next Questions: An Update on Higher Risk Myelodysplastic Syndromes.
Clin Lymphoma Myeloma Leuk Volume: 24 Page(s): 573 - 582
09/01/2024 Authors: Hochman MJ; DeZern AE -
Favorable outcomes in MDS and oligoblastic AML-MR after reduced-intensity conditioning allogeneic bone marrow transplantation with post-transplantation cyclophosphamide.
Bone Marrow Transplant Volume: 59 Page(s): 1178 - 1180
08/01/2024 Authors: Sinanidis I; Hochman MJ; Tsai H-L; Randall MP; Bonilla B; Varadhan R; Ambinder AJ; Jones RJ; DeZern AE; Karantanos T -
Management of patients with concurrent clonal plasma cell and myeloid disorders: A single center descriptive case series.
Leuk Res Rep Volume: 22 Page(s): 100469
01/01/2024 Authors: Hochman MJ; Gerber GF; Imus PH; Ali SA; DeZern AE -
Prognostic impact of secondary versus de novo ontogeny in acute myeloid leukemia is accounted for by the European LeukemiaNet 2022 risk classification.
Leukemia Volume: 37 Page(s): 1915 - 1918
09/01/2023 Authors: Hochman MJ; Othus M; Hasserjian RP; Ambinder A; Brunner A; Percival M-EM; Hourigan CS; Swords R; DeZern AE; Estey EH -
The Times, They Are A-Changing: The Impact of Next-Generation Sequencing on Diagnosis, Classification, and Prognostication of Myeloid Malignancies With Focus on Myelodysplastic Syndrome, AML, and Germline Predisposition.
Am Soc Clin Oncol Educ Book Volume: 43 Page(s): e390026
06/01/2023 Authors: Gurbuxani S; Hochman MJ; DeZern AE; Shimamura A -
Chronic myeloid leukemia (CML) evolves from Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs) with unexpected frequency.
Int J Hematol Volume: 117 Page(s): 456 - 462
03/01/2023 Authors: Hochman MJ; Smith BD; Karantanos T; Braunstein EM; Gojo I; Jain T; Streiff MB; Moliterno AR; DeZern AE -
On the basis of sex: outcomes in myelodysplastic syndromes.
Lancet Haematol Volume: 10 Page(s): e83 - e85
02/01/2023 Authors: Hochman MJ; DeZern AE -
Myelodysplastic syndrome and autoimmune disorders: two sides of the same coin?
Lancet Haematol Volume: 9 Page(s): e523 - e534
07/01/2022 Authors: Hochman MJ; DeZern AE